Laurens Parmentier, Edward Vermeersch, Sandra Van Vlierberghe
{"title":"通过使用各种交联化学物质的3D生物打印再现骨细胞外基质。","authors":"Laurens Parmentier, Edward Vermeersch, Sandra Van Vlierberghe","doi":"10.3389/fbioe.2025.1506122","DOIUrl":null,"url":null,"abstract":"<p><p>Bioprinting allows to spatially organize cellular niches influencing mechanobiology into tissue engineered constructs thereby aiming to achieve a similar functional complexity as the various tissues present within bone. Natural polymer hydrogel matrices are favorably selected as part of many bioinks thanks to their level of mimicry with the bone osteoid matrix. More specifically, a variety of biophysical and biochemical cues targeting osteogenesis can be presented towards cells encapsulated in bioprinted constructs. This review focusses on delineating bioprinting targeting osteogenesis based on the printing approach (deposition-versus light-based bioprinting) and crosslinking chemistry utilized (chain- versus step-growth crosslinking). Moreover, the cell-biomaterial interactions at play within these constructs are addressed in line with currently established mechanobiology concepts. The delicate interplay between the presented cues from the encapsulating matrix, the used printing process and the maturity, source and concentration of the used cell type finally dictates the osteoregenerative outcome of a bioprinted construct. Given the advantages towards cell encapsulation associated with step-growth systems, there is a huge need to evaluate these systems in comparison to the heavily reported chain-growth systems (predominantly gelatin-methacryloyl or GelMA) towards the bioprinting of constructs serving osteogenesis. Moreover, multiple bioprinting strategies should be combined to tackle key challenges in the field and enable functional and scalable hierarchical constructs serving osteogenesis with incorporation of vascularization and innervation.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1506122"},"PeriodicalIF":4.8000,"publicationDate":"2025-06-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177472/pdf/","citationCount":"0","resultStr":"{\"title\":\"Recapitulating the bone extracellular matrix through 3D bioprinting using various crosslinking chemistries.\",\"authors\":\"Laurens Parmentier, Edward Vermeersch, Sandra Van Vlierberghe\",\"doi\":\"10.3389/fbioe.2025.1506122\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Bioprinting allows to spatially organize cellular niches influencing mechanobiology into tissue engineered constructs thereby aiming to achieve a similar functional complexity as the various tissues present within bone. Natural polymer hydrogel matrices are favorably selected as part of many bioinks thanks to their level of mimicry with the bone osteoid matrix. More specifically, a variety of biophysical and biochemical cues targeting osteogenesis can be presented towards cells encapsulated in bioprinted constructs. This review focusses on delineating bioprinting targeting osteogenesis based on the printing approach (deposition-versus light-based bioprinting) and crosslinking chemistry utilized (chain- versus step-growth crosslinking). Moreover, the cell-biomaterial interactions at play within these constructs are addressed in line with currently established mechanobiology concepts. The delicate interplay between the presented cues from the encapsulating matrix, the used printing process and the maturity, source and concentration of the used cell type finally dictates the osteoregenerative outcome of a bioprinted construct. Given the advantages towards cell encapsulation associated with step-growth systems, there is a huge need to evaluate these systems in comparison to the heavily reported chain-growth systems (predominantly gelatin-methacryloyl or GelMA) towards the bioprinting of constructs serving osteogenesis. Moreover, multiple bioprinting strategies should be combined to tackle key challenges in the field and enable functional and scalable hierarchical constructs serving osteogenesis with incorporation of vascularization and innervation.</p>\",\"PeriodicalId\":12444,\"journal\":{\"name\":\"Frontiers in Bioengineering and Biotechnology\",\"volume\":\"13 \",\"pages\":\"1506122\"},\"PeriodicalIF\":4.8000,\"publicationDate\":\"2025-06-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12177472/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Bioengineering and Biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.3389/fbioe.2025.1506122\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1506122","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
Recapitulating the bone extracellular matrix through 3D bioprinting using various crosslinking chemistries.
Bioprinting allows to spatially organize cellular niches influencing mechanobiology into tissue engineered constructs thereby aiming to achieve a similar functional complexity as the various tissues present within bone. Natural polymer hydrogel matrices are favorably selected as part of many bioinks thanks to their level of mimicry with the bone osteoid matrix. More specifically, a variety of biophysical and biochemical cues targeting osteogenesis can be presented towards cells encapsulated in bioprinted constructs. This review focusses on delineating bioprinting targeting osteogenesis based on the printing approach (deposition-versus light-based bioprinting) and crosslinking chemistry utilized (chain- versus step-growth crosslinking). Moreover, the cell-biomaterial interactions at play within these constructs are addressed in line with currently established mechanobiology concepts. The delicate interplay between the presented cues from the encapsulating matrix, the used printing process and the maturity, source and concentration of the used cell type finally dictates the osteoregenerative outcome of a bioprinted construct. Given the advantages towards cell encapsulation associated with step-growth systems, there is a huge need to evaluate these systems in comparison to the heavily reported chain-growth systems (predominantly gelatin-methacryloyl or GelMA) towards the bioprinting of constructs serving osteogenesis. Moreover, multiple bioprinting strategies should be combined to tackle key challenges in the field and enable functional and scalable hierarchical constructs serving osteogenesis with incorporation of vascularization and innervation.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.